Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Sees Revenues Climb, Earnings Double in Q1

NEW YORK, April 23 (GenomeWeb News) - Molecular Devices' revenues grew and its earnings doubled during the first quarter, the company said yesterday.


Revenues increased to $27.3 million, from $24.6 million during the year-ago period.


Research and development costs decreased to $4 million, from $4.7 million during the first quarter last year.


The company's net income soared to $1.4 million, or $.1 per share, from $0.7 million, or $.05 per share, for the same period last year.


As of March 31, Molecular Devices had $50.4 million in cash and cash equivalents, and no short-term investments.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.